Greatbatch Inc and Aleva Neurotherapeutics SA of Switzerland are to collaborate on a new device for deep brain stimulation (DBS) for treating Parkinson’s disease and essential tremor. Simultaneously the US company is to lead a Series C financing round for Aleva.
